J&J | JNJ - Sales Revenues

Stock Price
243.47
Daily Change
-1.70 -0.69%
Monthly
8.48%
Yearly
48.70%
Q1 Forecast
234.97

J&J reported $24.6B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Abbott USD 11.46B 90M Dec/2025
Amgen USD 9.9B 340M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Bayer EUR 9.66B 1.08B Sep/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Biogen USD 2.28B 250M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
CONMED USD 373.2M 35.3M Dec/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
J&J USD 24.6B 610M Dec/2025
Medtronic USD 9B 39M Jan/2026
Merck USD 16.4B 880M Dec/2025
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Novartis USD 13.91B 144M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025
Vertex Pharmaceuticals USD 3.19B 110M Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025
Zoetis USD 2.4B 0 Dec/2025